Beijing Suncadia Pharmaceuticals Co., Ltd
Clinical trials sponsored by Beijing Suncadia Pharmaceuticals Co., Ltd, explained in plain language.
-
New hope for stubborn high cholesterol: experimental drug SHR-1918 enters trials
Disease control Not yet recruitingThis study tests an experimental drug called SHR-1918 for people with high cholesterol that remains high despite taking statins and PCSK9 inhibitors. About 126 adults will receive either SHR-1918 or a placebo to see if the drug safely lowers cholesterol levels over 12 to 24 weeks…
Phase: PHASE2, PHASE3 • Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated May 17, 2026 11:23 UTC
-
New drug aims to tame dangerous blood fats in 360-Person trial
Disease control Not yet recruitingThis study tests a new medicine called SHR-1918 for people with high triglycerides, a type of fat in the blood that can raise heart risk. About 360 adults will receive either the drug or a placebo for up to 48 weeks to see if it safely lowers triglyceride levels. The goal is to c…
Phase: PHASE3 • Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated May 17, 2026 11:15 UTC
-
New heart failure drug candidate enters first human safety trial
Disease control Not yet recruitingThis early-stage study tests a single injection of SHR-4658 in 48 healthy people and those with high blood pressure to see if it is safe and how the body handles it. The goal is to gather initial safety data for a potential heart failure treatment. Participants must be 18-55 and …
Phase: PHASE1 • Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated May 14, 2026 12:03 UTC